Evidence map›Paper›PMID 21858447›Full record

ArticleInternational journal of hematology2011

Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma.

Yasushi Terasaki, Hiroki Yamamoto, Hiroaki Kiyokawa, Hirokazu Okumura, Katsuhiko Saito, Ryo Ichinohasama, Youichi Ishida

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in a patient with hepatitis B virus-related liver cirrhosis: A case report.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yasushi TerasakiDivision of Internal Medicine, Toyama City Hospital, 2-1, Hokubu-machi, Imaizumi, Toyama, 939-8511, Japan. terasaki@tch.toyama.toyama.jp.
Hiroki YamamotoDivision of Internal Medicine, Toyama City Hospital, 2-1, Hokubu-machi, Imaizumi, Toyama, 939-8511, Japan.
Hiroaki KiyokawaDivision of Internal Medicine, Toyama City Hospital, 2-1, Hokubu-machi, Imaizumi, Toyama, 939-8511, Japan.
Hirokazu OkumuraDivision of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.
Katsuhiko SaitoDivision of Pathology, Toyama City Hospital, Toyama, Japan.
Ryo IchinohasamaDivision of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Youichi IshidaDivision of Internal Medicine, Toyama City Hospital, 2-1, Hokubu-machi, Imaizumi, Toyama, 939-8511, Japan.
Toyama City Hospital · JPTohoku University · JPToyama Prefectural Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma usually confined to the body cavities of predominantly immunosuppressed patients infected with human herpes virus-8 (HHV-8). In PEL, malignant cells are usually negative for B-cell markers, such as CD19, CD20, and CD79a, but are positive for activation and plasma cell-related markers, such as CD30, CD38, and CD138. It has been reported that HHV-8-unrelated PEL shows high expression of B-cell markers, which is referred to as PEL-like lymphoma. Here, we report two cases of HHV-8-unrelated HIV-negative PEL-like lymphoma in which malignant cells regressed spontaneously after effusion drainage alone. These cells expressed B-cell markers, such as CD20. No chemotherapy was given to either patient, as they were of an advanced age, and both achieved a complete response by effusion drainage alone. One showed a complete response for 16 months after effusion drainage, and the other has survived for 11 months with a complete response. This suggests that sufficient drainage of serous effusion may induce and maintain a complete response in some patients with HHV-8-unrelated HIV-negative PEL-like lymphoma, which represents an excellent treatment option for elderly patients with this disease.

Indexed as

DrainageHIV SeronegativityAged, 80 and overFemaleHerpesvirus 8, HumanHumansLymphoma, Primary EffusionMaleRemission Induction

Identifiers

PMID21858447
OpenAlexW2075437921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.